Strides Fights COVID-19-Led Sales Slump With Endo Assets, Sputnik V
New CDMO Alliance Expected
After a COVID-19-led manufacturing halt at its India facility and a slowdown in US launches hit Strides during the first quarter of FY22, the Indian firm is trying to fight back with an acquisition of assets from Endo and a growth strategy for Stelis Biopharma’s vaccines business, led by Sputnik V.
